A multicenter, prospective study of biodegradable-polymer sirolimus-eluting stent, Ultimaster in comparison with durable-polymer everolimus-eluting stent
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Sirolimus (Primary) ; Everolimus
- Indications Coronary artery disease
- Focus Therapeutic Use
- 29 Dec 2017 New trial record
- 02 Nov 2017 Results presented at the 29th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics